Navigating the New Medical Affairs Landscape: Data, Impact, and
the Evolving MSL Role
“Right now, we are blind and don’t know what’s working and what’s not. We need to connect the dots on medical impact to make better decisions, be more strategic, and see the trends. It’s crucial for the future of medical affairs".
In this episode of Veeva’s podcast series, “What Pharma Needs Next”, Christoph Bug, VP Global Medical at Veeva, speaks to several industry experts about the ongoing transformation of medical affairs to become a more strategic, data-driven decision-making organization.
Learn more about measuring medical impact.
